Why Mars is doubling down on U.S. manufacturing with a $2bn plan to expand capacity and jobs

Mars, Incorporated has unveiled plans to invest $2 billion into U.S.-based manufacturing by the end of 2026, underscoring its long-standing commitment to domestic production in food, confectionery, and pet-care. The American family-owned conglomerate, headquartered in McLean, Virginia, said the initiative is designed to enhance capacity, boost automation, and position the company to meet fast-evolving consumer demand.

The business, known for iconic brands such as M&M’S, SNICKERS, Royal Canin, Ben’s Original, PEDIGREE, and SHEBA, noted that 94 percent of products sold in the United States are already made locally. This new investment follows more than $6 billion that Mars has committed to U.S. manufacturing in the past five years, a period in which it added approximately 9,000 U.S.-based jobs across its 49-state footprint.

Claus Aagaard, chief financial officer of Mars, Incorporated, said in prepared remarks that the U.S. market remains “the company’s most important growth engine” and that the capital allocation would help the business “grow with consumers, deliver for partners, and create lasting economic impact” in the communities where it operates.

How will Mars’s $2 billion U.S. manufacturing investment impact capacity, job creation, and strategic acquisitions?

A central element of the plan is the opening of a $240 million Nature’s Bakery facility in Salt Lake City, Utah, which will be officially inaugurated this week. Spanning 339,000 square feet, the facility is expected to produce nearly one billion snack bars annually and generate more than 230 new jobs in the region. Nature’s Bakery, acquired by Mars in 2020, is considered a high-growth brand aligned with consumer preferences for non-GMO, plant-based snacking.

Earlier this year, Mars also opened a $450 million Royal Canin dry pet food plant in Lewisburg, Ohio. The factory—the largest of its kind for Royal Canin globally—has created up to 270 new jobs and significantly boosted capacity for premium pet nutrition products in the domestic market.

Industry observers suggest these expansions illustrate how Mars is pursuing growth by investing in brands with strong health and wellness credentials while modernizing its legacy production network. Analysts note that the U.S. footprint now includes 38 factories and supports more than 70,000 associates in addition to veterinary clinics, labs, and 16 global and regional offices.

Institutional sentiment has generally viewed the announcement as a sign of confidence in long-term U.S. consumer demand. Analysts said Mars’s focus on domestic manufacturing, coupled with automation upgrades, positions it to achieve productivity gains and reduce exposure to global supply-chain disruptions and commodity price volatility, particularly around key inputs like cocoa, sugar, and edible oils.

What broader economic and policy trends frame Mars’s $2 billion U.S. manufacturing strategy, and how does it align with industry reshoring efforts?

Mars’s investment comes amid a broader wave of domestic manufacturing commitments across multiple sectors, from semiconductors to automotive and consumer packaged goods. More than $2 trillion worth of U.S.-based manufacturing projects have been announced in 2025, according to industry trackers.

This factory-building trend has been supported by a combination of market dynamics and policy incentives. Recent trade frictions and tariffs have prompted many multinationals to shorten supply chains, while tax credits and subsidies under legislation such as the CHIPS and Science Act and the Inflation Reduction Act have reinforced the business case for domestic production. Although Mars’s investments are not directly tied to these programs, analysts note that the structural rationale is similar: local manufacturing reduces geopolitical exposure, lowers transportation emissions, and strengthens ties with U.S. consumers.

Economic development officials in Utah and Ohio have welcomed Mars’s projects, citing their job creation potential and alignment with state-level initiatives to attract advanced manufacturing. Market commentators also note that the expansion supports broader policy objectives around reshoring and economic security.

Observers said Mars’s approach mirrors that of other global manufacturers, including Siemens, General Motors, and Eli Lilly, which have announced multi-billion-dollar investments in new and upgraded U.S. plants in 2025. Analysts believe these initiatives collectively signal a manufacturing renaissance, particularly as companies integrate advanced automation, sustainable operations, and product innovation.

What is the outlook for Mars’s U.S. manufacturing network beyond 2026, and what future growth areas are likely to benefit?

Looking ahead, Mars is expected to continue investing in its U.S. operations even after the current $2 billion program is complete. The company has indicated that future capital expenditure will include upgrades to legacy facilities to further automate production, integrate digital twin platforms, and deploy predictive maintenance technologies. These systems are designed to reduce downtime, enhance efficiency, and improve capacity planning.

Sustainability is likely to be a core focus of the next phase. Analysts expect Mars to expand investments in renewable energy, sustainable packaging solutions, and resource efficiency. This will allow the company to align its operations with corporate environmental, social, and governance (ESG) goals as well as evolving regulatory frameworks.

Innovation will also be critical. Mars is expected to leverage its U.S.-based research and development capabilities to accelerate the launch of healthier snacks, plant-based foods, and specialized pet nutrition products. The company’s recent acquisitions of Nature’s Bakery and Trü Frü provide platforms for growth in high-demand categories, and analysts anticipate more investment to scale these brands domestically.

Institutional investors and industry watchers believe Mars’s strategy of deepening its U.S. manufacturing footprint will help it maintain strong brand equity while protecting margins from cost pressures. If the company succeeds in aligning its expanded network with consumer preferences for better-for-you products and sustainable operations, analysts believe it could drive steady growth despite macroeconomic uncertainty.

Mars has not disclosed facility-level financial targets or expected returns for the current initiative, but executives reiterated that the full $2 billion program will be deployed by the end of 2026. Industry observers note that the company has historically taken a long-term view of capital allocation, reinvesting in its manufacturing footprint rather than pursuing short-term cost cutting. Given Mars’s century-long history in the U.S. and its family-owned structure, analysts expect the business to continue adopting a generational approach to manufacturing investment. This strategy allows Mars to prioritize network resilience, invest in advanced automation technologies, and respond to evolving consumer preferences without being overly constrained by quarterly performance metrics. By maintaining this disciplined approach, industry participants believe Mars can ensure its brands remain competitive for decades to come, even as supply chain dynamics, commodity costs, and consumer expectations shift.